Drug safety

Monitoring and prevention of adverse effects from medications.

Key developments include merck's remigromig meets primary endpoint in diabetic macular edema trial amid safety concerns, new england journal of medicine retracts amgen's tavneos clinical trial amid data manipulation allegations, xanax recalled nationwide over failed quality specifications, among other significant events and policy changes.

Source: Geo Health Space